Stephanie J. Nahas, MD

December 03, 2021

Dr Andrew Charles shares how he eases patient anxieties over lifestyle changes for preventive migraine therapy.

December 03, 2021

Rebecca Erwin Wells, MD, MPH, details the effectiveness of lifestyle changes for preventative migraine treatment.

November 19, 2021

Expert neurologists share their goals and patient considerations for preventive migraine therapy.

November 19, 2021

Andrew C. Charles, MD, provides a historical perspective on the agents traditionally used for preventive migraine therapy.

May 27, 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed the role of clinicians in determining migraine treatment eligibility.

May 21, 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed the barriers to the use of preventive medicines.

May 07, 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University detailed the ways clinicians can tailor their treatment regimens better.

April 23, 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University detailed the reasons fremanezumab stands out among a crowded migraine treatment landscape.

April 19, 2021

The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed 2 research projects she led presented at AAN 2021 on the efficacy and safety of fremanezumab.